Vitrolife Group completes refinancing facility backed by leading Nordic Banks

Rhea-AI Summary

Vitrolife (OTC:VTRLY) has successfully secured a EUR 300 million loan agreement comprising a term loan and revolving credit facility. The financing arrangement, backed by leading Nordic banks including Nordea, SEB, and new lender AB Svensk Exportkredit, features a three-year tenor with two one-year extension options.

The term loan will be utilized to refinance existing debt, while the revolving credit facility will be available for general corporate purposes. The addition of AB Svensk Exportkredit as a new lender highlights Vitrolife Group's strong credit profile and export focus.

Positive

• Secured substantial EUR 300 million financing facility
• Added new lender AB Svensk Exportkredit while maintaining existing banking relationships
• Obtained flexible terms with 3-year tenor and two one-year extension options
• Demonstrated strong credit profile through successful refinancing

Negative

• None.

GOTHENBURG, Sweden, July 1, 2025 /PRNewswire/ -- Vitrolife AB (publ) has today renewed and signed a loan agreement of EUR 300 million comprising of term loan and revolving credit facility. The term loan will be used to refinance existing debt and the revolving credit facility will be available for general corporate purposes. 

The loan agreement is backed by leading Nordic banks, with Nordea and SEB renewing their commitments and AB Svensk Exportkredit joining as a new lender, underscoring the Vitrolife Group's strong credit profile and focus on export. The loan agreement has a tenor of three-years and includes two one-year extension options.

"We appreciate the support from our existing and new banking partners in connection with this refinancing. This successful transaction underlines the confidence in the Vitrolife Group," says Bronwyn Brophy O'Connor, CEO of the Vitrolife Group.

Gothenburg, 1 July 2025
VITROLIFE AB (publ)
Bronwyn Brophy O'Connor, CEO

Contact:
Amelie Wilson, Investor relations, external corporate communications and executive support, awilson@vitrolife.com 

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/vitrolife-group-completes-refinancing-facility-backed-by-leading-nordic-banks,c4176840

The following files are available for download:

https://mb.cision.com/Main/1031/4176840/3539534.pdf

Vitrolife Group completes refinancing facility backed by leading Nordic Banks

FAQ

What is the size of Vitrolife's (VTRLY) new loan agreement?

Vitrolife has secured a EUR 300 million loan agreement comprising both a term loan and revolving credit facility.

Which banks are backing Vitrolife's (VTRLY) new financing facility?

The loan agreement is backed by Nordea and SEB (existing lenders) and AB Svensk Exportkredit (new lender).

What is the duration of Vitrolife's (VTRLY) new loan agreement?

The loan agreement has a three-year tenor with two one-year extension options.

How will Vitrolife (VTRLY) use the new financing facility?

The term loan will be used to refinance existing debt, while the revolving credit facility will be available for general corporate purposes.